NASDAQ : QSI
Quantum-Si incorporated — Key statistics
Healthcare · Medical Devices · United States
Last price 1.46 USD (Oct 30, 2026, 4:00 PM EST) · Market cap 319.57M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 275.79M |
| Enterprise Value | 109.18M |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 5, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 198.95M |
| Shares Outstanding | 218.88M |
| Shares Change (YoY) | +31.21% |
| Shares Change (QoQ) | +0.61% |
| Owned by Insiders (%) | 17.32% |
| Owned by Institutions (%) | 22.34% |
| Float | 180.22M |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 171.83 |
| Forward PS | 137.17 |
| PB Ratio | 1.53 |
| P/TBV Ratio | 1.53 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | 68.03 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 9.97 |
| Quick Ratio | 9.36 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | -49.11% |
| Return on Assets (ROA) | -25.72% |
| Return on Invested Capital (ROIC) | -27.72% |
| Return on Capital Employed (ROCE) | -50.74% |
| Weighted Average Cost of Capital (WACC) | 21.69% |
| Revenue Per Employee | $11,069 |
| Profits Per Employee | -$679,441 |
| Employee Count | 145 |
| Asset Turnover | 0.01 |
| Inventory Turnover | 0.35 |
Taxes
| Measure | Value |
|---|
| Income Tax | -95,000 |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 3.25 |
| 52-Week Price Change | -41.40% |
| 50-Day Moving Average | 1.05 |
| 200-Day Moving Average | 0.96 |
| Relative Strength Index (RSI) | 49.09 |
| Average Volume (20 Days) | 9,979,634 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 13.21M |
| Short Previous Month | 11.83M |
| Short % of Shares Out | 6.03% |
| Short % of Float | 7.33% |
| Short Ratio (days to cover) | 1.38 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 1.61M |
| Gross Profit | 562,000 |
| Operating Income | -92.16M |
| Pretax Income | -98.61M |
| Net Income | -98.52M |
| EBITDA | -87.36M |
| EBIT | -92.16M |
| Loss Per Share | -$0.46 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 111.74M |
| Total Debt | 3.25M |
| Net Cash | 166.61M |
| Net Cash Per Share | $0.76 |
| Equity (Book Value) | 180.20M |
| Book Value Per Share | 0.82 |
| Working Capital | 107.14M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | -92.45M |
| Capital Expenditures | -1.24M |
| Depreciation & Amortization | 4.80M |
| Net Borrowing | n/a |
| Free Cash Flow | -93.69M |
| FCF Per Share | -$0.43 |
Margins
| Measure | Value |
|---|
| Gross Margin | 35.02% |
| Operating Margin | -5,742.06% |
| Pretax Margin | -6,144.17% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -31.21% |
| Shareholder Yield | -31.21% |
| Earnings Yield | -36.39% |
| FCF Yield | -33.97% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $2.28 |
| Price Target Difference | 81.19% |
| Analyst Consensus | Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (3Y) | 107.12% |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Measure | Value |
|---|
| Altman Z-Score | 5.67 |
| Piotroski F-Score | 2 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |